Presentations highlight real‑world dosing and titration patterns in youth, and post‑prandial glucose management strategies using inhaled insulin ...

Barclays 28th Annual Global Healthcare Conference March 11, 2026 2:00 PM EDTCompany ParticipantsAdam Steensberg - President ...

Leerink Global Healthcare Conference 2026 March 10, 2026 10:40 AM EDTCompany ParticipantsBrian Lian - President, CEO ...

Although tolvaptan bests fluid restriction at raising plasma sodium concentration, 19% of patients experience overcorrection ...

Medication can significantly improve the ability to initiate tasks, sustain attention, and complete responsibilities”— ...

Mercy Health’s Amherst Sleep Center is springing forward with changes that expand access to care, improve communication and enhance the patient experience to support healthier sleep, according to a ...

The Hoffman Process, popular with a growing number of CEOs and celebrities, is often described as ‘10 years of therapy in a week.’ ...

A web-based tool that incorporates patient preference in antidepressant selection was associated with a significant decrease ...

More than half of Ozempic users prescribed the drug for obesity alone are stopping or reducing their doses within a year, ...

Omada Health (NASDAQ:OMDA) Q4 2025 Earnings Call Transcript March 6, 2026 Operator: Good day, and thank you for standing by. Welcome to the Omada Health Fourth Quarter 2025 Earnings Conference Call.

An informational overview of Ivím Health's compounded semaglutide and tirzepatide telehealth program, including GLP-1 ID cost breakdown, weekly provider check-in structure, clinical claims analysis, a ...

Ropeginterferon alfa-2b-njft is currently FDA-approved and marketed as BESREMi (R) for the treatment of adults with polycythemia vera (PV). The Company is seeking a ropeginterferon alfa-2b-njft label ...